Olme­sar­tan Medox­omil CAS 144689-63-4

Iden­ti­fi­ca­tion Prop­er­ties Safe­ty Data Spec­i­fi­ca­tions & Oth­er Information Links

Iden­ti­fi­ca­tion

CAS Number

144689-63-4

Name

Olme­sar­tan Medox­omil

Syn­onyms

Olme­sar­tan medox­omil [INN] [USAN] (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2′-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylate (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxy-2-propanyl)-2-propyl-1-{[2′-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1H-imidazole-5-carboxylate [ACD/IUPAC Name] (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylate (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2′-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylate (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl-4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2′-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-carboxylat (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl-4-(2-hydroxy-2-propanyl)-2-propyl-1-{[2′-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1H-imidazol-5-carboxylat [Ger­man] [ACD/IUPAC Name] 144689-63-4 [RN] 1H-Imi­­da­­zole-5-car­boxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester [ACD/​Index Name] 1H-imi­­da­­zole-5-car­boxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester 4-(1-hydroxy-1-méthyléthyl)-2-propyl-1-{[2′-(2H-tétrazol-5-yl)biphényl-4-yl]méthyl}-1H-imidazole-5-carboxylate de (5-méthyl-2-oxo-1,3-dioxol-4-yl)méthyle 4-(2-Hydroxy-2-propanyl)-2-propyl-1-{[2′-(1H-tétrazol-5-yl)-4-biphénylyl]méthyl}-1H-imidazole-5-carboxylate de (5-méthyl-2-oxo-1,3-dioxol-4-yl)méthyle [French] [ACD/IUPAC Name] 6M97XTV3HD 7787 Benevas Benicar [Trade name] olmésar­tan médox­omil [French] [INN] olme­sartán medox­omi­lo [Span­ish] [INN] olme­sar­tanum [Latin] [INN] olme­sar­tanum medox­omilum [Latin] [INN] Olme­tec [Trade name] олмесартан медоксомил [Russ­ian] [INN] أولميسارتان ميدوكسوميل [Ara­bic] [INN] (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2′-(1H-tetrazol-5-yl)-[1,1′-biphenyl] 4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2′-(1H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)-4-(2-h (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2′-(1H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-i mida­­zole-5-car­boxy­late (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2-(1h-tetrazol-5-yl)-[1,1-biphenyl]4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1h-imidazole-5-carboxylate (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2′-(1H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2′-(1H-tetrazol-5-yl)-[1,1′-biphenyl]4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2′-(2H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2-(2h-tetrazol-5-yl)biphenyl-4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1h-imidazole-5-carboxylate (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2′-(2H-tetrazol-5-yl)biphenyl-4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(1-hydroxy-1-methyl-ethyl)-2-propyl-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate (5-methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazole-5-carboxylate [144689-63-4] 10.1124/mol.112.084152 1H-Imi­­da­­zole-5-car­boxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2′-(1H-tetrazol-5-yl)(1,1′-biphenyl)-4-yl)methyl)-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2′-(1H-tetrazol-5-yl)(1,1′-biphenyl)-4-yl)methyl-1H-Imidazole-5-carboxylic acid, (5-methyl -2-oxo-1,3-dioxol-4-yl) methyl ester 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2′-(1Htetazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2′-(1H-tetazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylicacid(5-Methyl-2-oxo-1,3-dioxol-4-yl)methylester 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2-(1H-tetazol-5-yl)[1,1-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylicacid(5-Methyl-2-oxo-1,3-dioxol-4-yl)methylester 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-(5-methyl-2-oxo-1,3-dioxol-4-(5-methyl-2-oxo-1,3-dioxol-4-(5-methyl-2-oxo-1,3-dioxol-4-(5-methyl-2-oxo-1,3-dioxol-4-y)methyl ester 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2?-(1H-tetazol-5-yl)[1,1?-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2?-(2H-tetrazol-5-yl)[1,1?-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2’-(2H-tetrazol-5-yl)[1,1’-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-2′-(1h-tetazol-5-yl)1,1′-biphenyl-4-ylmethyl-1H-imidazole-5-carboxylic acid (5-me thyl-2-oxo-1,3-dioxol-4-yl)methyl ester 5-(1-Hydroxy-1-methylethyl)-2-propyl-3-[2′-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-imidazole-4-carboxylic acid 5-methyl-2-oxo-[1,3]dioxol-4-ylmethy 5-(1-hydroxy-1-methylethyl)-2-propyl-3-[2-(1h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3h-imidazole-4-carboxylic acid 5-methyl-2-oxo-[1,3]dioxol-4-ylmethyl ester 5-(1-Hydroxy-1-methyl-ethyl)-2-propyl-3-[2′-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-imidazole-4-carboxylic acid 5-methyl-2-oxo-[1,3]dioxol-4-ylmethyl ester 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-4-imidazolecarboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester Benicar® Benicar®|CS-866|Olme­tec® Benicar, Benevas, Olvance BR-72894 CS-866DM MFCD00914967 MFCD00944911 [MDL num­ber] N-acetyl­d­i­naline | NI4014200 Olme­sar­tan (medox­omil) Olme­tec® Olme­tec ; Benicar ; CS 866 Olvance Phar­­makon1600-01505205 SC-866RN UNII :6M97XTV3HD UNII-6M97XTV3HD

Mol­e­c­u­lar Structure

SMILES

CCCc1nc(c(n1Cc2ccc(cc2)c3ccccc3c4[nH]nnn4)C(=O)OCc5c(oc(=O)o5)C)C(C)(C)O

Std­InChI

InChI=1S/C29H30N6O6/c1-5-8-23-30-25(29(3,4)38)24(27(36)39-16-22-17(2)40-28(37)41-22)35(23)15-18-11-13-19(14-12-18)20-9-6-7-10-21(20)26-31-33-34-32-26/h6-7,9-14,38H,5,8,15-16H2,1-4H3,(H,31,32,33,34)

Std­InChIKey

UQGKUQLKSC­SZ­­GY-UHF­F­­FAOYSA-N

Mol­e­c­u­lar Formula

C29H30N6O6

Mol­e­c­u­lar Weight

558.59

MDL Number

MFCD00944911

Safe­ty Data

RIDADR

NONH for all modes of trans­port

WGK Germany

3 

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our Olme­sar­tan Medox­omil CAS 144689-63-4

Stan­dard

Enter­prise stan­dard

GMP

LCF­DA

Basic Patent Situation

US expiry date	20100209
EU expiry date	20120812
JP expiry date	20100614

Pack­age

Accord­ing to cus­tomer require­ments to pack­ag­ing

Stor­age

Under the room tem­per­a­ture and away from light

Appli­ca­tion

Used as the Angiotensin II Recep­tor Antag­o­nist.

Links

This prod­uct is devel­oped by our R&D com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Ltd(http://​www​.cam​ing​.com/), and here is the cor­re­spond­ing linkhttp://​www​.cam​ing​.com/​o​l​m​e​s​a​r​t​a​n​-​m​e​d​o​x​o​m​i​l​-​c​a​s​-​1​4​4​6​8​9​-​6​3​-4/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you short­ly (Please change screen to hor­i­zon­tal for com­plete brows­ing if you are check­ing Wat­son on your mobile phone).